Technical analysis of Dare Bioscience, Inc. (DARE): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis.
Price Performance
| 1 month | -5.56% |
| 3 months | -66.57% |
| Year-to-date | -62.41% |
| 1 year | -64.61% |
| 3 years | -87.27% |
| 5 years | -96.58% |
52-Week Range
| 52-week High | $3.78 |
| 52-week Low | $0.69 |
| Avg Volume (90d) | 468K |
Technical Indicators
| SMA 50 | $1.17 |
| SMA 200 | $1.78 |
| Beta | 0.90 |
| 30-day Volatility (annualised) | 126.4% |
| Price vs SMA 50 | -38.1% |
| Price vs SMA 200 | -59.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.96 | |
| 2025-11 | $1.84 | -6.1% |
| 2025-12 | $1.93 | +4.9% |
| 2026-01 | $1.81 | -6.2% |
| 2026-02 | $1.70 | -6.1% |
| 2026-03 | $1.82 | +7.1% |
| 2026-04 | $2.28 | +25.3% |
| 2026-05 | $2.23 | -2.2% |
| 2026-06 | $2.11 | -5.4% |
| 2026-07 | $1.22 | -42.2% |
| 2026-08 | $0.76 | -37.6% |
| 2026-09 | $0.73 | -4.7% |
Price
| Price | $0.73 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -18.96 |
| EV / EBITDA | -0.53 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -12.08 |
| Current Ratio | 0.99 |